Kenya Plans to Refinance More Eurobonds, Renegotiate Bank Loans
'The best way to deal with the eurobonds is the way we dealt with the 2027s,' he said in an interview in the capital, Nairobi, on Wednesday. He was referring to February's sale of $1.5 billion of 2036 eurobonds, the proceeds of which were used to retire securities that were falling due in two years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Wall Street Journal
an hour ago
- Wall Street Journal
Japan's Inflation Stays Well Above BOJ's 2% Target
Japan's consumer inflation remained well above the central bank's target of 2% in July, reinforcing expectations of a coming interest-rate increase. Consumer inflation excluding volatile fresh food prices climbed 3.1% from a year earlier last month, compared with June's 3.3% rise, government data showed Friday. That was higher than the 3.0% increase expected in a poll of economists by data provider Quick.
Yahoo
2 hours ago
- Yahoo
Dave Ramsey Caller's Husband Had A Secret $100,000 Credit Card Debt. After Getting Caught, Insisted That 'Having A Budget Is Embarrassing'
A recent episode of 'The Ramsey Show' featured a caller from Boston named Jennifer who revealed a massive breach of trust in her marriage—her husband secretly racked up $100,000 in debt while managing all of their household finances. 'I found out in the fall about $100,000 of debt that I didn't know about,' Jennifer told hosts Dave Ramsey and Ken Coleman. 'It was credit cards that I didn't know about and also tax debt.' Debt Paid Off, But Bigger Issues Remain Despite the shock, the couple worked aggressively to eliminate the debt and are now halfway through Ramsey's 'Baby Step 3,' saving for an emergency fund. But Jennifer said the real problem wasn't just the money; it was her husband's ongoing behavior. Don't Miss: The same firms that backed Uber, Venmo and eBay are investing in this pre-IPO company disrupting a $1.8T market — 'Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. You can Shop Top Mortgage Rates Personalized rates in minutes A quicker path to financial freedom Your Path to Homeownership After discovering the hidden debt, Jennifer insisted they combine their finances, begin using a budgeting app, and attend counseling. Her husband went along with it, but not willingly. 'He says sharing accounts and the budget are the worst decision he's ever made,' she said. 'Even having a budget is embarrassing to him.' Jennifer added that her husband still goes on solo trips, spends impulsively, and refuses to track expenses. 'The latest argument from this weekend was because I just realized that after months, he still hasn't switched his direct deposit over,' she said. Ramsey pointed out that this wasn't a financial issue anymore. 'This is not a financial problem, hun. It's a marriage problem. It's manifesting itself in the finances,' he said. 'I don't really want to be married is what he's actually saying. I'm afraid. I hope not.' Trending: Kevin O'Leary Says Real Estate's Been a Smart Bet for 200 Years — Coleman added that the husband's behavior shows someone who came from an entitled background, which Jennifer confirmed. Ramsey and Coleman both suggested the husband has likely never faced consequences for his actions and is avoiding accountability. 'Behavior is a language,' Ramsey said, referencing a phrase from another co-host John Delony. 'What he's doing is screaming, 'I don't really want to build a life together. I want to be able to do whatever I want to do when I want to do it.'' Jennifer said she's stayed in the marriage because she still wants to try. 'If this marriage could be fixed, would you do whatever it takes?' Coleman asked. Jennifer responded, 'Absolutely. I wouldn't have stayed. He's been lying since the beginning of our marriage.' Coleman was straightforward. He told Jennifer she needed to draw a real boundary, telling him, 'If you don't change, this is done.' He added that she should get help from a marriage counselor or pastor to figure out the next steps. 'I think it's that serious,' Coleman said. Read Next: In a $34 Trillion Debt Era, The Right AI Could Be Your Financial Advantage — The ECG Hasn't Changed in 100 Years — Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? APPLE (AAPL): Free Stock Analysis Report TESLA (TSLA): Free Stock Analysis Report This article Dave Ramsey Caller's Husband Had A Secret $100,000 Credit Card Debt. After Getting Caught, Insisted That 'Having A Budget Is Embarrassing' originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Yahoo
2 hours ago
- Yahoo
Sarepta pushes off debt payments in bid to regain financial footing
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Dive Brief: Sarepta on Thursday said it's reached agreements that remove about $700 million from a pile of debt due in 2027. The private agreements with debt holders will allow Sarepta to exchange the 1.25% convertible senior notes due in 2027 for $602 million worth of 4.875% convertible senior notes due in 2030, up to 6.7 million shares of Sarepta stock and about $123 million in cash. Separately, the company entered into a private placement of about 1.4 million shares. The transaction 'significantly enhances our balance sheet flexibility and strengthens our financial position,' Sarepta CEO Doug Ingram said in a statement. Sarepta will still have $450 million in existing convertible notes due in 2027. Dive Insight: Sarepta's fortunes have dramatically changed over the course of the last year. In June 2024, the company was riding high on an expanded approval for its Elevidys gene therapy treatment for Duchenne muscular dystrophy. Its shares soared, topping $160 that month. But the trajectory for Elevidys sales changed when the company reported a patient death in March of this year and then another in June. The Food and Drug Administration in July asked Sarepta to stop shipping the therapy, a request that Sarepta initially refused. While the FDA allowed Elevidys shipments to resume for certain patients in the U.S. in late July, the sales outlook for the therapy is uncertain, and investors have punished Sarepta's stock. The shares were trading at less than $20 apiece early Thursday. The questions about Elevidys sales also raised new concerns about whether Sarepta could repay looming debt and make hundreds of millions of dollars in milestone payments to its partner, Arrowhead Pharmaceuticals. Even after laying off more than a third of its staff, analysts questioned whether Sarepta would need to make more cuts to meet its commitments. Sarepta is answering those questions with a series of financial transactions. In addition to the latest refinancing of 2027 debt, Sarepta last week announced that it planned to sell its entire equity stake in Arrowhead. After both moves, 'we are well positioned to fully fund our pipeline and meet our near-term obligations,' Sarepta CEO Ingram said in the company's statement Thursday. The transactions will help ease investors' immediate concerns about Sarepta's balance sheet, Leerink Partners analyst Joseph Schwartz wrote in a Thursday note to investors. 'With the near-term overhang removed, we think investor focus will remain squarely on how demand for Elevidys trends following the safety events and regulatory saga,' he wrote. Recommended Reading 4 more biotechs cut staff amid market tumult Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
